Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

ULTRASENSITIVE MEASURE OF HUMAN MUTAGENESIS: CONNECTING THE EXPOSOME TO DISEASE

Export to Word (http://www.niehs.nih.gov//portfolio/index.cfm/portfolio/grantdetail/grant_number/R01ES026222/format/word)
Principal Investigator: Bielas, Jason H
Institute Receiving Award Fred Hutchinson Cancer Research Center
Location Seattle, WA
Grant Number R01ES026222
Funding Organization National Institute of Environmental Health Sciences
Award Funding Period 01 Jul 2016 to 30 Jun 2021
DESCRIPTION (provided by applicant): PROJECT SUMMARY Somatic mutations are the driving force behind carcinogenesis and other age-related diseases, yet the mechanisms underlying their genesis in humans are ambiguous. This proposal seeks to resolve fundamental processes of nuclear mutagenesis and ascertain the utility of monitoring somatic mutation as a biomarker of individual environmental exposure within a well-characterized population. These objectives are now feasible thanks to the development of a novel mutation detection technology termed CypherSeq, which utilizes circular barcoded templates, rolling circle amplification, and massively parallel sequencing to accurately quantify somatic mutation throughout the genome with unprecedented sensitivity. First, the CypherSeq method will be used to establish a genome-wide profile of somatic mutation in disease-free humans, and test how the frequency, distribution, and spectrum of mutation change with age throughout the genome. Second, proliferating and quiescent human cells will be treated with known mutagens, and induced mutagenesis will be tracked by CypherSeq. These experiments will explore the relationships between cell proliferation, transcription, DNA repair, and somatic mutation, while also uncovering highly mutable regions of the genome, which might serve as sites to monitor acute and chronic mutagen exposure in human populations. Further, this Aim will also test the hypothesis that proliferation is required for repair and mutation fixation within non- transcribed regions of the genome. Lastly, in the third Aim, robust mutational target sites will be characterized and used to monitor mutation frequency in blood draws from individuals who have endured a long-term, carcinogenic exposure to smoky coal. This cross-sectional study will test the hypothesis that underlying the carcinogenicity of smoky coal is its potential to increase the frequency of somatic mutation in exposed individuals. As such, it is expected that increased lifetime exposure to smoky coal will positively correlate with mutation induction. Successful completion of the proposed Aims would provide new insights into human mutagenesis, and highlight the potential utility of monitoring in vivo mutation induction as a biomarker of mutagenic environmental exposure; and thus identify individuals with an elevated risk of developing cancer. Ultimately, mutation-based biomarkers have the potential to stratify cancer risk, providing a basis to direct medical intervention, lifestyle changes (i.e. limiting mutagen exposure), early diagnosis, and/or the application of chemopreventive measures, and thus save lives.
Science Code(s)/Area of Science(s) Primary: 15 - Exposure Assessment/Exposome
Publications See publications associated with this Grant.
Program Officer Daniel Shaughnessy
Back
to Top